Vitamin D represses retinoic acid-dependent transactivation of the retinoic acid receptor-β2 promoter: The AF-2 domain of the vitamin D receptor is required for transrepression

Endocrinology

Volumn 140, Issue 6, 1999, Pages 2898-2907

  Jiménez Lara, Ana M ^a   Aranda, Ana ^a  

^a CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; RETINOIC ACID; RETINOIC ACID RECEPTOR BETA2; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR;

ARTICLE; BINDING AFFINITY; DNA BINDING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR BINDING; TRANSACTIVATION;

EID: 0033279006     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.6.6770     Document Type: Article

References (46)

1. The nuclear receptor superfamily: The second decade
2. The RXR heterodimers and orphan receptors
3. Vitamin D receptor interaction with specific DNA: Association as a 1,24-dihydroxyvitamin D3-modulated heterodimer
4. RARs and RXRs: Evidence for two autonous transactivation functions (AF-1 and AF-2) and heterodimerization in vivo
5. Transcriptional activation and dimerization functions in the human vitamin D receptor
6. The nuclear receptor ligand-binding domain: Structure and function
7. The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the full-length receptors to direct repeats
8. Natural vitamin D3 response elements formed by inverted palindromes: Polarity-directed ligand sensitivity of vitamin D receptor-retinoid X receptor heterodimer-mediated transactivation
9. Direct repeats as selective response elements for the thyroid hormone, retinoic acid and vitamin D receptors
10. Vitamin D interferes with transactivation of the growth hormone gene by thyroid hormone and retinoic acid
11. Vitamin D receptors repress basal transcription and exert dominant negative activity on triiodothyronine-mediated transcriptional activity
12. Identification of a retinoic aid responsive element in the retinoic acid receptor β gene
13. Characterization of an autoregulated response element in the mouse retinoic acid receptor type β gene
14. Functional characterization of a natural retinoic acid responsive element
15. The promoter context is a decisive factor in establishing selective responsiveness to nuclear class II receptors
16. Crystal structure of the ligand binding domain of the human nuclear receptor RXRα
17. Crystal structure of the RARγligand-binding domain bound to all trans retinoic acid
18. Nuclear receptor coactivators
19. Co-activators and co-repressors in the integration of transcriptional responses
20. Cooperativity in transactivation between retinoic acid receptor and TFIID requires an activity analogous to E1A
21. Residues in the TATA-binding protein required to mediate a transcriptional response to retinoic acid in EC cells
22. Adenovirus E1A functions as a cofactor for retinoic acid receptor β (RARβ) through direct interaction with RARβ
23. Adenovirus E1A activation domain binds the basic repeat in the TATA box transcription factor
24. Retinoic acid and thyroid hormone indice gene expression through a common responsive element
25. Nuclear receptor that identifies a novel retinoic acid response pathway
26. Cloning and expression of full-length cDNA encoding human vitamin D receptor
27. Role of CBP/P300 in nuclear receptor signaling
28. AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors
29. Retinoid-dependent in vitro transcription mediated by the RXR/RAR heterodimer
30. A cyclic AMP response element is involved in retinoic acid-dependent RARβ2 promoter activation
31. Ligand-dependent occupancy of the retinoic acid receptor β2 promoter in vivo
32. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding
33. Polarity-specific activities of retinoic acid receptors determined by a co-repressor
34. A transcriptional co-repressor that interacts with nuclear hormone receptors
35. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor
36. Ligand modulates the conversion of DNA-bound vitamin D3 receptor (VDR) homodimers into VDR retinoid X receptors heterodimers
37. Selective effects of ligands on vitamin D3 receptor- and retinoid X receptor-mediated gene activation in vivo
38. Unliganded T3R, but not its oncogenic variant v-erbA, suppresses RAR-dependent transactivation by titrating out RXR
39. Evidence for ligand-dependent folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction
40. Mapping of the domains of the interaction of the vitamin D receptor and steroid receptor coactivator-1
41. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
42. A family of transcriptional adaptor proteins targeted by the E1A oncoprotein
43. Rubenstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP
44. Transcriptional factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription
45. The N-terminal domain of transcription factor IIB is required for direct interaction with the vitamin D receptor and participates in vitamin D-dependent transcription
46. A tissue-specific enhancer confers Pit-1 dependent morphogen inducibility and autoregulation on the Pit-1 gene